Evolent Health Stock News

Genesee Capital Advisors LLC bought a new position in shares of Evolent Health, Inc. (NYSE:EVH) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 105,503 shares of the technology companys stock, valued at approximately $3,271,000. Evolent Health makes up approximately 1.6% of Genesee Capital Advisors []

Cubist Systematic Strategies LLC lifted its stake in shares of Evolent Health, Inc. (NYSE:EVH) by 45.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,661 shares of the technology companys stock after acquiring an additional 7,400 shares during the []

JPMorgan Chase & Co. upgraded shares of Evolent Health (NYSE:EVH) from a neutral rating to an overweight rating in a research report report published on Thursday, Analyst Ratings Network reports. JPMorgan Chase & Co. currently has $37.00 price target on the technology companys stock, up from their prior price target of $26.00. Several other equities []

Evolent Health, Inc. (NYSE:EVH)s stock price gapped up before the market opened on Thursday . The stock had previously closed at $27.79, but opened at $29.37. Evolent Health shares last traded at $29.43, with a volume of 16,461 shares changing hands. A number of analysts have recently weighed in on EVH shares. TheStreet upgraded Evolent []

Related Stocks: EVH , TLMD , CMAX , EA , CHRS , EXC , GDP , TBT , OAS , CANO , MARA ,

DUBLIN--(BUSINESS WIRE)--The "Sawmills and Wood Preservation Plants Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2027, NAIC 321100" report from Plunkett Research Ltd has been added to ResearchAndMarkets.com''s offering. This report contains vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings Sawmills and Wood Preservation Plants Industry (U

WASHINGTON, Nov. 5, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today a

Evolent Health, Inc.'s (EVH) CEO Seth Blackley on Q3 2021 Results - Earnings Call Transcript

Evolent Health (EVH) delivered earnings and revenue surprises of 0.00% and -1.64%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

WASHINGTON, Oct. 18, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced i

NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced today that it has completed the sale of Vital Decisions

Evolent Health Inc. is a small innovative healthcare services outfit bridging the gap between provider and payer. Sweeping shifts in the healthcare industry are attracting widespread technological inn

There's a rumor going around that Walgreens Boots Alliance wants to acquire the struggling administrative assistant business.

Swirling buyout rumors continue to bring the bulls to the healthcare stock.